Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
- PMID: 25870311
- DOI: 10.1136/thoraxjnl-2015-207080
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
Keywords: ABCA3.
Comment on
-
A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.Thorax. 2015 May;70(5):442-50. doi: 10.1136/thoraxjnl-2014-205998. Epub 2015 Feb 24. Thorax. 2015. PMID: 25714615 Free PMC article. Clinical Trial.
-
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma.Thorax. 2015 May;70(5):458-67. doi: 10.1136/thoraxjnl-2014-206067. Epub 2015 Mar 6. Thorax. 2015. PMID: 25746630
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical